Is ATHX or FCPT a better dividend investment in 2026?

ATHX currently yields 14814.81% with a 5% 5-year dividend growth rate. FCPT yields 6.05% with 5% growth. The better choice depends on your goal: ATHX offers higher current income.

What is the dividend yield difference between ATHX and FCPT?

ATHX has a forward dividend yield of 14814.81% ($2.00/share annually). FCPT yields 6.05% ($1.43/share annually). The yield gap is 14808.76 percentage points.

Home › Compare › ATHX vs FCPT

ATHX vs FCPT: Dividend Comparison 2026

ATHX yields 14814.81% · FCPT yields 6.05%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ATHX wins by $2677980877459223040.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ATHX

● Live price

14814.81%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2677980877459223040.00M

Annual income

$2,642,887,894,030,851,000,000,000.00

Full ATHX calculator →

FCPT

● Live price

6.05%

Share price

$23.65

Annual div

$1.43

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.1K

Annual income

$5,775.28

Full FCPT calculator →

Portfolio growth — ATHX vs FCPT

📍 ATHX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ATHX	FCPT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ATHX + FCPT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ATHX pays

FCPT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATHX

Annual income on $10K today (after 15% tax)

$1,259,259.26/yr

After 10yr DRIP, annual income (after tax)

$2,246,454,709,926,223,300,000,000.00/yr

FCPT

Annual income on $10K today (after 15% tax)

$514.49/yr

After 10yr DRIP, annual income (after tax)

$4,908.99/yr

At 15% tax rate, ATHX beats the other by $2,246,454,709,926,223,300,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATHX + FCPT for your $10,000?

ATHX: 50%FCPT: 50%

100% FCPT50/50100% ATHX

Portfolio after 10yr

$1338990438729611520.00M

Annual income

$1,321,443,947,015,425,400,000,000.00/yr

Blended yield

98.69%

📊

Analyst Conviction Gap

Where Wall Street is split right now

ATHX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-152.6

Piotroski

2/9

FCPT

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$27.00

+14.2% upside vs current

Range: $25.00 — $29.00

Altman Z

1.4

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATHX buys

FCPT buys

No recent congressional trades found for ATHX or FCPT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricATHXFCPT

Forward yield	14814.81% ✓	6.05%
Annual dividend / share	$2.00 ✓	$1.43
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$2677980877459223040.00M ✓	$49.1K
Annual income after 10y	$2,642,887,894,030,851,000,000,000.00 ✓	$5,775.28
Total dividends collected	$2675658490367706112.00M ✓	$24.1K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: ATHX vs FCPT ($10,000, DRIP)

Year	ATHX Portfolio	ATHX Income/yr	FCPT Portfolio	FCPT Income/yr	Gap
1← crossover	$1,492,181	$1,481,481.48	$11,401	$700.92	+$1.48M → ATHX
2	$208,198,432	$206,601,797.37	$13,064	$864.84	+$208.19M → ATHX
3	$27,163,301,697	$26,940,529,375.29	$15,051	$1,072.48	+$27163.29M → ATHX
4	$3,314,004,807,579	$3,284,940,074,762.82	$17,442	$1,337.22	+$3314004.79M → ATHX
5	$378,099,822,241,034	$374,553,837,096,924.30	$20,340	$1,677.08	+$378099822.22M → ATHX
6	$40,342,336,842,848,056	$39,937,770,033,050,150.00	$23,880	$2,116.57	+$40342336842.82M → ATHX
7	$4,025,655,551,654,171,600	$3,982,489,251,232,324,000.00	$28,241	$2,689.36	+$4025655551654.14M → ATHX
8	$375,711,296,730,478,150,000	$371,403,845,290,208,200,000.00	$33,660	$3,442.07	+$375711296730478.06M → ATHX
9	$32,797,180,774,179,380,000,000	$32,395,169,686,677,763,000,000.00	$40,456	$4,439.95	+$32797180774179380.00M → ATHX
10	$2,677,980,877,459,223,000,000,000	$2,642,887,894,030,851,000,000,000.00	$49,063	$5,775.28	+$2677980877459223040.00M → ATHX

ATHX vs FCPT: Complete Analysis 2026

ATHX — Stock

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.

Full ATHX Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →

📬

Get this ATHX vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATHX vs SCHD ATHX vs JEPI ATHX vs O ATHX vs KO ATHX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.